Global Healthcare M&A Report – September 2025: 27 Deals Disclosed with Total Value of USD 4.7 Billion

According to incomplete statistics from Arterial Intelligence, in September 2025, there were a total of 27 mergers and acquisitions in the global healthcare sector, with a disclosed total transaction value of approximately $4.701 billion (about 33.553 billion RMB). In the Chinese market, there were 5 mergers and acquisitions, with a disclosed total transaction value of approximately $40.8324 million; in overseas markets, there were 22 mergers and acquisitions, with a disclosed total transaction value of approximately $4.66 billion.

Thermo Fisher Scientific Acquires Solventum's Purification and Filtration Business for $4.1 Billion in Largest M&A Deal of the Month

CRDMO Company Symeres Acquires DGr Pharma to Enhance Regulatory Expertise and Early-Stage Drug Development Services

On September 17, 2025, CRDMO company Symeres acquired DGr Pharma. This move aims to enhance Symeres' regulatory expertise and expand its capabilities in providing early drug development services to biopharmaceutical clients. The acquisition is designed to strengthen the company’s ability to offer integrated services and accelerate the Investigational New Drug (IND) support process. Keensight Capital, a private equity firm focused on pan-European growth investments, supported this transaction.

Bausch Health Completes Acquisition of Durect to Advance Phase III Clinical Trial of Larsucosterol for Alcoholic Hepatitis

On September 11, 2025, Bausch Health acquired all outstanding shares of DURECT for $1.75 per share in cash, with a total upfront cash payment of approximately $63 million at the closing of the transaction. Locust Walk served as the exclusive financial advisor to DURECT. Following the completion of the tender offer and merger, DURECT Corporation became a wholly owned subsidiary of Bausch Health, and all DURECT common stock ceased trading on NASDAQ.

GTCR Acquires Zentiva from Advent International, Closing European Generic Drug Market Deal

On September 11, 2025, private equity firm GTCRAnnouncementAdvent International Acquires Zentiva. The announcement highlights significant developments in the pharmaceutical and investment sectors. Zentiva has been owned by Advent since 2018, during which time it expanded its operations and solidified its position as a major player in the European generics market. Details of the financial terms of the deal were not disclosed. Both Advent and GTCR are recognized for their extensive experience in managing investments across various industries, including healthcare.

Completion of Equity Delivery: Tellgen's Pathology Sector Welcomes Another Significant Layout

On September 29, 2025, Tellgen Corporation announced that it had completed the first phase of the equity transfer for the acquisition of a controlling stake in Wuhan HealthCare Biotechnology Co., Ltd. on September 28, officially becoming the controlling shareholder of HealthCare Biotechnology. According to the agreement between both parties, this transaction will be implemented in three phases, ultimately acquiring 82.00% of HealthCare Biotechnology's shares for a total amount of 328 million yuan. In the initial phase of the transaction, Tellgen acquired 72.8630% of HealthCare Biotechnology's shares at a cost of 291,451,900 yuan, completing share registration changes, business registration modifications, and related payment procedures.

Medical Device Developer SAM Medical Acquires TyTek to Expand Emergency Product Line

On September 17, 2025, SAM Medical, a medical device developer, completed the acquisition of TyTek, a company renowned globally for its expertise in emergency medical products. This move expands SAM Medical's portfolio in pre-hospital emergency care by integrating TyTek Medical’s specialized products, such as thoracic decompression needles. Both companies are well-known for focusing on providing critical tools for first responders and healthcare professionals.

Edwards Completes Acquisition of Vectorious for $497 Million

On September 4, 2025, Edwards completed the acquisition of Vectorious Medical Technologies, an Israeli startup, in a cash transaction worth $497 million. This is the total amount paid after the second phase of the deal: Edwards acquired approximately 52% of the company two years ago and is now purchasing the remaining 48%. Vectorious is an Israeli innovation company whose first product is dedicated to heart failure management, providing heart failure patients with new and precise monitoring data.

Glooko, a diabetes data management service provider, announces the completion of its acquisition of Monarch Medical Technologies

On September 24, 2025, Glooko, Inc., a global leader in digital diabetes management platforms, completed the acquisition of Monarch Medical Technologies on September 23 for an undisclosed amount. This acquisition will integrate Monarch’s EndoTool® Inpatient Glucose Management System (GMS) into Glooko’s product portfolio, marking the company's expansion from outpatient and home settings to inpatient glucose control, creating an integrated "hospital-to-home" diabetes management platform covering the entire process.

Digital health company Flight Health acquires Alteris Health to develop AI operating system for medical practices

On September 22, 2025, digital health company Flight Health announced the acquisition of Alteris Health. This acquisition aims to create what the two companies describe as the first comprehensive artificial intelligence operating system specifically tailored for medical practices. The integration of Flight Health's existing technology with Alteris Health's automation capabilities will focus on streamlining operations within independent medical practices. By consolidating resources, the new system aims to address inefficiencies in administrative processes while enhancing overall practice management.

Genomic Analysis Solutions Provider SeqOne Announces Acquisition of Congenica to Expand AI-Driven Genomic Solutions for Personalized Medicine

On September 9, 2025, SeqOne, a provider of genomic analysis solutions, announced the acquisition of Congenica, combining the expertise of both companies in AI-driven genomic solutions. This merger aims to expand their global reach and enhance the capability to analyze genetic data for personalized medicine applications. The acquisition marks a significant step forward in advancing precision medicine on an international scale.

Integration Health, a medical staffing and end-to-end solutions provider, acquires ECMO Advantage to expand critical care services nationwide in China

On September 18, 2025, Integration Health, a medical staffing and end-to-end solutions provider, acquired ECMO Advantage. This strategic acquisition brings together two of the most significant ECMO service providers in the industry, combining their expertise, resources, and hospital relationships under Integration Health's unified platform. The acquisition enables Integration Health to continue its growth in the rapidly expanding ECMO services market, as the ECMO sector continues to grow with increasing recognition and expanding applications of its clinical benefits.

Aesthetic Clinic Skin Science Aesthetics Announces Joining Spa Medicca

On September 18, 2025, Spa Medicca, the leading platform for medical practices focused on beauty and wellness, announced that Skin Science Aesthetics has joined its platform. This partnership expands Spa Medicca's growing network of affiliated clinics and is supported by Seven Hills Capital.

Xiyuan Technology Strategically Acquires Yice Medical Management to Deepen Business Layout in Hospital Management and Performance Consulting

On September 13, 2025, Shanghai Xiruan Technology Co., Ltd. officially announced the strategic acquisition of Guangzhou Yice Medical Management Technology Co., Ltd. As a holding subsidiary of Xiruan Technology, Yice Medical Management will focus on professional development in the field of hospital management and performance consulting. This acquisition marks the deep integration of both companies’ businesses, jointly building a "software + data + consulting"三位一体 product and service system to help medical institutions establish lean operational systems and achieve digital and intelligent upgrades.

Global Health and Wellness Company Zinzino AB Completes Acquisition of Truvy to Expand Distribution in North America, Latin America, and South Korea

On September 25, 2025, Zinzino AB, a global health and wellness company, completed the acquisition of Truvy. This acquisition enables Zinzino to gain access to Truvy's operations and resources, with the aim of strengthening its presence in North America, Latin America, and South Korea. This move marks an important step for Zinzino in expanding its international influence. By integrating Truvy’s established network and infrastructure into its own operations, Zinzino plans to enhance its ability to distribute products within these regions.

DHL Supply Chain Acquires SDS Rx to Expand Same-Day Healthcare Delivery Services in the U.S.

On September 12, 2025, logistics provider DHL Supply Chain acquired SDS Rx, a specialized delivery network focused on healthcare logistics in the United States. This acquisition will integrate SDS Rx’s operations into DHL's Life Sciences & Healthcare division, enhancing its capabilities in same-day and last-mile delivery services. The move comes amid a continued rise in demand for specialized pharmaceutical logistics and patient-centered delivery solutions.

EqualizeRCM Acquires Assets of Revenue Cycle Solutions

On September 11, 2025, EqualizeRCM, a revenue cycle management services provider, acquired the assets of Revenue Cycle Solutions. Details of the acquisition terms were not disclosed. This acquisition marks a significant advancement for EqualizeRCM in expanding its capabilities and influence in the healthcare revenue management sector.

Only 3 M&A events at most are displayed in each of the above fields.Welcome ImmediatelyScan the QR code to add the assistant.ObtainCompleteMonthly ReportAndApply for a Free Trial Database, please inquire if added: